Paclitaxel: all 2,132 studies that test it
Page 22 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.
- Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002922Phase 2
- Paclitaxel in Treating Patients With Early-Stage Bladder CancerCompletedNCT00002917Phase 1/2
- Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
- Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian CancerCompletedNCT00002894Phase 3
- Combination Chemotherapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002888Phase 3
- Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerCompletedNCT00002852Phase 3
- High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerCompletedNCT00002837Phase 1/2
- Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00002826Phase 2
- Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial CancerTerminatedNCT00002819Phase 3
- Combination Chemotherapy for Patients With Brain CancerCompletedNCT00002814Phase 2
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian CancerCompletedNCT00002734Phase 1
- Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002711Phase 1
- Combination Chemotherapy in Patients With Advanced Urinary Tract CancerCompletedNCT00002684Phase 2
- Paclitaxel or Docetaxel in Treating Women With Advanced Breast CancerCompletedNCT00002662Phase 3
- Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland CancerCompletedNCT00002632Phase 2
- Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast CancerStatus unknownNCT00002628Phase 1/2
- Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast CancerStatus unknownNCT00002627Phase 1/2
- Paclitaxel Plus Topotecan in Treating Patients With Solid TumorsCompletedNCT00002587Phase 1
- Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerCompletedNCT00002568Phase 3
- Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal CancerCompletedNCT00002562Phase 2
- Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung CancerCompletedNCT00002519Phase 1
- Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton PharmaceuticalsCompletedNCT00002189Phase 2
- Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal CarcinomatosisCompletedNCT00001569Phase 1
- Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00001499Phase 2
- A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast CancerCompletedNCT00001498Phase 2
- Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLCCompletedNCT00001450Phase 2
- A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2
- Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory MalignancyCompletedNCT00001387Phase 1
- A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer PatientsCompletedNCT00001384Phase 2
- A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001383Phase 1
- A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer PatientsCompletedNCT00001272Phase 1